Company / Income Tax
Vistagen Therapeutics, Inc. Income Tax History
FY2011-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$3.4K
FY2023
5-year range
$2.3K / $3.4K
FY2019-FY2023
Trend
+30.8%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $2,600 to $3,400 over the past 2 years.
Based on SEC 10-K filings.
$3,400 in FY2023 with a 5-year CAGR of +7.2%.
Increased from $2,600 to $3,400 over the past 2 years.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +7.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +7.2%, indicating consistent growth.
- In FY2023, income tax increased 30.8% year-over-year.
- Peak income tax was recorded in FY2014.
- Lowest income tax in the period was in FY2012.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -7.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | $3.4K | +30.8% |
| FY2022 | $2.6K | +0.0% |
| FY2021 | $2.6K | +8.3% |
| FY2018 | $2.4K | +4.3% |
| FY2017 | $2.3K | -37.8% |
| FY2014 | $3.7K | +131.3% |
| FY2012 | $1.6K | +0.0% |
| FY2011 | $1.6K | - |
As of FY2023 · SEC 10-K · Updated Jun 28, 2026